This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Boosting your savings for a house down payment is essential. Discover key tips that can help you increase your funds and prepare for homeownership.
18,205 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Demand for reliable baseload power is on the rise, and nuclear energy stands out as a steady option. Here’s why two n...
Eli Lilly’s GLP-1 drugs have changed the game in obesity and diabetes. This article explains why Lilly Sees More Deal...
Investing in niche AI infrastructure can offer outsized upside, but only with a plan. This article shows how buying P...
Circle just cleared a major regulatory milestone with a national bank charter. This could reshape how CRCL stock move...
In 2026, the budget airline reinventing itself is pulling ahead as it monetizes upgrades and smarter distribution, wh...
Two early leaders in the electric air taxi race collide with a policy signal that could tilt the field. This analysis...
A surprising analyst upgrade helped StubHub Holdings stock crush expectations this week. This article breaks down the...
Nu Holdings approves a $1 billion share buyback, triggering a stock jump that investors will watch closely. Here’s wh...
Bloom Energy has sprinted higher this year on an AI-powered energy story. As a late entrant, you’ll want a clear view...
Three social platforms are drawing fresh attention as growth meets reasonable prices. Here’s a practical, investor-fr...
A regional bank melt-up: this market moment could offer outsized gains, but it comes with sharp risks. Learn how to e...